SI190050: Sitagliptin-d4.HCl label-new Fmoc-Ser(α-L-Neu5Ac(Ac)4-(2-6)-α-D-GalNAc(Ac)2)-OH

Fmoc-Ser(α-L-Neu5Ac(Ac)4-(2-6)-α-D-GalNAc(Ac)2)-OH

19 / IgA1 synthetic Hinge Region peptide fragment from Val222 to Ser240 with glycosylation (α-GalNAc) at Thr228

43 / A peracetylated β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with a terminal carboxylic acid through a short butyl spacer

Neu5AC2Gal2GlcNAc2Man3GlcNAc2-Asn-Ahx-Biotin

6-Chloro-6-dehydro-17α-hydroxy-1

SI190050: Sitagliptin-d4.HCl label-new Fmoc-Ser(α-L-Neu5Ac(Ac)4-(2-6)-α-D-GalNAc(Ac)2)-OHC16H11D4F6N5O. HCl 447. 81 Antidiabetic Sitagliptin d4. HCl 7 [(3R) 3 Amino 1 oxo 4 (2,4,5 trifluorophenyl)butyl] 5,6,7,8 tetrahydro 3 (trifluoromethyl) 1,2,4 triazolo[4,3 a]pyrazine d4 HCl; Januvia d4